Intravitreal Eye Injection


Quiz: Do You Understand Intravitreal Eye Injection Treatments?

Test your knowledge by answering the following questions:


People with age-related macular degeneration may benefit from intravitreal eye injections.

Intravitreal eye injections of anti-VEGF medications may be used to treat diabetic macular edema, diabetic retinopathy, branch or central vein occlusion and age-related macular degeneration.

The three types of anti-VEGF drugs are bevacizumab, ranibizumab and aflibercept.

Your eye doctor will determine which of the three anti-VEGF drugs are the best treatment for your condition: bevacizumab, ranibizumab or aflibercept

Intravitreal eye injections are an outpatient procedure at the hospital.

You’ll receive your intravitreal eye injections at the ophthalmologist’s office, and the procedure will take between 15 and 30 minutes.

Intravitreal eye injections are quite painful.

Patients are often concerned that an injection of material into their eye will be a painful or scary procedure. In fact, after the first or second injection, patients become quite at ease with the idea that they will have these injections,

Slight bleeding on the white of the eye is normal after an intravitreal injection.

Following an intravitreal injection, you may feel pressure or grittiness in the eye, slight bleeding on the white of the eye and floaters in your vision. These are temporary and normal.

Diabetic Retinopathy

Do you know a family member, friend or associate at work that would benefit from this informative information sent to you by your eye clinic. Take the time to send them a link to this information.

Diabetic Retinopathy

Diabetic retinopathy is caused by changes in the blood vessels of the retina. People with type 1 and type 2 diabetes are at risk, and because there are often no symptoms in the early stages of diabetic retinopathy, regular eye exams combined with proper diabetes management is essential.